2019
DOI: 10.1016/j.jval.2019.04.1341
|View full text |Cite
|
Sign up to set email alerts
|

Pnd68 Cost-Effectiveness of Ocrelizumab Compared to Fingolimod or DMF in Relapsing-Remitting Multiple Sclerosis in Czech Republic

Abstract: Researchers have yet to identify therapies that can reverse or slow the progression of Alzheimer's disease and related dementias (ADRD), but four prescription drugs (donepezil, galantamine, memantine, and rivastigmine) have been recommended in AD treatment guidelines, having shown effects on the symptoms of AD. Despite the potential of these drugs to at least partially reduce AD's burden, relatively little is known about the current trends in the use of these drugs within the trajectory of dementia diagnoses a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance